The LP's Dilemma: When Should You Re-Up With an Underperforming Fund Manager?

The Question Nobody Wants to Ask

You committed $500K to a venture capital fund three years ago. The GP just sent the annual report: the portfolio is marked at 0.9x MOIC, below-benchmark TVPI, and several of the highest-conviction investments have been written down. Now the same GP is raising their next fund and asking you to re-up.

This is one of the most consequential — and least discussed — decisions that limited partners face. The venture capital and private equity industries are structurally designed to make re-up decisions difficult: information asymmetry favors the GP, social pressure within investor networks is real, and the fear of missing out on a recovery vintage creates powerful psychological bias toward continuation.

Let's cut through the noise and build a framework for making this decision rationally.

The Persistence Myth: What the Data Actually Shows

The traditional argument for re-upping with underperforming managers relies on "persistence" — the idea that top-performing fund managers consistently outperform across vintages. For decades, academic research supported this view, most notably a 2005 Kaplan and Schoar study showing significant persistence in private equity returns.

But more recent research has complicated this narrative considerably:

• Persistence has weakened significantly since 2000. A 2020 study by Harris, Jenkinson, Kaplan, and Stucke found that while persistence existed in funds raised before 2000, it has diminished substantially for more recent vintages. The private equity market has become more competitive, and the informational advantages that drove persistence have eroded.
• Persistence is asymmetric. Bottom-quartile funds show more persistence than top-quartile funds. In other words, bad managers are more likely to stay bad than good managers are to stay good. This is precisely the wrong direction for re-up optimism.
• In venture capital specifically, persistence is stronger than in buyouts — but it's concentrated among a very small number of elite firms. If your GP isn't Sequoia, Benchmark, or a comparable franchise, historical persistence data offers limited comfort.

A Diagnostic Framework for the Re-Up Decision

Rather than relying on broad statistical patterns, we recommend evaluating five specific factors:

1. Diagnose the Source of Underperformance

Not all underperformance is created equal. The critical distinction is between systematic and idiosyncratic causes:

• Market-driven underperformance: If the fund's vintage coincided with a market downturn (e.g., a 2021 vintage fund suffering from the 2022–2023 valuation reset), the underperformance may be temporary and shared across the entire peer group. Check the fund's performance against its vintage-year benchmark. A fund that is 0.8x MOIC in a vintage where the median is 0.7x is actually outperforming.
• Strategy-driven underperformance: Did the GP chase a sector thesis that didn't pan out? Did they move upmarket or downmarket from their historical sweet spot? Strategy drift is a more concerning signal than market-wide correction.
• Execution-driven underperformance: Are portfolio companies failing because of poor GP involvement, inadequate board governance, or inability to help with follow-on fundraising? This is the most damning category and the hardest to diagnose from the outside.

2. Evaluate Team Stability and Composition

Fund performance is ultimately driven by people. Key questions:

• Has there been meaningful turnover among senior investment professionals?
• Are the partners who drove historical outperformance still active and engaged?
• Has the team added junior partners who are now leading deals? If so, what is their individual track record?
• How is carry distributed across the team? Concentrated carry creates key-person risk; widely distributed carry may dilute accountability.

A common pattern: a fund's best vintage was driven by one or two exceptional partners who have since departed. The remaining team raises subsequent funds on the strength of historical returns they didn't generate. This is one of the most common traps in LP re-up decisions.

3. Assess Fund Size Relative to Strategy

Fund size bloat is a silent killer of returns. If the GP raised a $200M Fund II that generated a 3.0x net MOIC, and is now raising a $600M Fund IV, the mathematical reality of deploying three times the capital into the same opportunity set virtually guarantees lower returns. This is especially true in early-stage venture, where the best opportunities are often small.

Ask the GP directly: how will you deploy a meaningfully larger fund without sacrificing return quality? If the answer involves moving into later stages, larger check sizes, or new geographies, you're effectively investing in a different strategy with the same team — and the historical track record may not be relevant.

4. Examine the GP's Self-Awareness and Adaptation

How the GP communicates about underperformance tells you more than the performance numbers themselves. Red flags include:

• Blaming market conditions exclusively without acknowledging any decision-making errors
• Highlighting unrealized markups in recent investments to offset realized losses
• Changing valuation methodologies between reporting periods
• Refusing to provide granular company-level performance data

Green flags include:

• Candid post-mortems on failed investments with specific lessons learned
• Concrete changes to investment process, team structure, or portfolio construction based on those lessons
• Willingness to reduce fund size or management fees in response to underperformance
• GP commit increasing as a percentage of fund size (eating their own cooking)

5. Consider Your Broader Portfolio Context

The re-up decision shouldn't happen in isolation. Consider:

• Vintage year diversification: Skipping a fund creates a gap in your vintage year exposure. Is that gap acceptable given your overall portfolio construction?
• Relationship value: Some GP relationships provide co-investment access, deal flow visibility, or network benefits that have value beyond fund returns. Quantify this if possible.
• Opportunity cost: Capital allocated to a re-up is capital unavailable for a new manager relationship. Are there emerging managers or strategies that might offer better risk-adjusted returns?

When to Walk Away: Clear Signals

Based on our analysis of institutional LP decision-making patterns, there are several scenarios where walking away is almost always the right call:

• Bottom-quartile performance across two consecutive vintages. One bad fund is forgivable; two suggests a structural problem.
• Significant team turnover without adequate succession planning. The fund is no longer the same entity you originally underwrote.
• Fund size growth exceeding 2.5x from a strong-performing vintage. The strategy-capital mismatch is too large to overcome.
• The GP cannot clearly articulate what went wrong and what has changed. Lack of self-awareness is the most reliable predictor of continued underperformance.
• Declining GP commit percentage. If the general partners are reducing their personal capital at risk, they're telling you something.

When to Re-Up: The Contrarian Case

Conversely, there are scenarios where re-upping with an underperforming manager is actually the best risk-adjusted decision:

• Vintage-specific underperformance with strong process. If the fund's underperformance is clearly attributable to market timing (deploying at peak valuations) rather than poor selection, and the team has demonstrated strong selection ability in other vintages, re-upping into a potentially better vintage makes sense.
• The GP is reducing fund size and fees in response. This signals integrity and alignment. A GP who takes a smaller fund after underperformance is prioritizing returns over AUM — exactly what you want.
• You have deep conviction in a thesis that hasn't yet played out. Some investment strategies are inherently long-cycle. If you believe the thesis is sound but early, patience may be rewarded.

Practical Advice for the Re-Up Conversation

Don't make this decision passively. Request a dedicated LP meeting focused on performance attribution. Ask for company-level performance data, not just fund-level aggregates. Speak with other LPs — especially those who are not re-upping — to understand their reasoning. And if you decide to walk away, do so respectfully but firmly. The relationship may be valuable in the future, and the private equity world is small.

The most important principle: never re-up out of inertia or social obligation. Every commitment should be underwritten independently, as if you were evaluating the manager for the first time. If the answer to "would I invest in this manager today, knowing what I know?" is anything other than a clear yes, your capital is better deployed elsewhere.